PS Ratio: 908.28

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 908.28 is 66% below its estimated 3-year average of 2687.25, near the low end of its estimated 3-year range (887.22–15733.38).

As of 2026-10-06T17:11:30.996Z. 31.00% below its estimated 12-month average of 1316.28.

CGON PS Ratio Metrics

P/S vs. estimated history

At 908.28, P/S is at an extreme level, where the multiple carries little signal — higher than 1% of readings in its estimated 3-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for CG Oncology Inc. (CGON)?

The P/S ratio for CGON stock is 908.28.

Is CG Oncology Inc.'s P/S ratio high or low?

The P/S ratio of 908.28 is 66% below its estimated 3-year average of 2687.25, near the low end of its estimated 3-year range (887.22–15733.38).

What is the estimated TTM average P/S ratio for CG Oncology Inc. (CGON)?

The estimated TTM average P/S ratio for CGON stock is 1316.28.

Showing the most recent 260 of 676 data points. The chart above shows the full history.

Related Metrics